FoldRx Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
When a protein faiils to fold properly, its function is lost and disease may follow. FoldRx Pharmaceuticals hopes to become the first company to develop agents that target misfolded proteins to stop the many diseases they cause.